KETAMINE CLINICS

Critical Quiet.
Continuous Insight.

Prioritizing Patient Safety

Ketamine infusions may cause sudden shifts in blood pressure, heart rate, and breathing.1,2 The Vios Monitoring System delivers continuous, real-time insight into these changes to help maintain a calm, uninterrupted infusion experience.

Real-Time Oversight for Every Infusion

Using lightweight, wearable sensors, the Vios Monitoring System delivers continuous tracking of key physiological parameters throughout ketamine infusions—with customizable alerts for changes in any monitored vital sign.

Continuous Non-Invasive Blood
Pressure (CNIBP)

Unlike conventional monitors that rely on intermittent readings, Vios’ novel, FDA-cleared algorithm provides continuous blood pressure monitoring without cuff inflations; detects transient changes often missed by intermittent checks.


ADDITIONAL PARAMETERS

Heart Rate & ECG

Real-time cardiac monitoring to identify rhythm changes.

Respiratory Rate & SpO₂

Breath-by-breath respiratory and oxygenation monitoring with waveform visualization.

Enhancing Clinical Efficiency Through Integrated Monitoring

Centralized Oversight

View multiple treatment rooms from one Vios Central Station, reducing room-to-room vital checks.

Reusable Sensor Hardware

Reusable components help control ongoing program costs.

Easy Integration

Works over existing Wi-Fi and IT infrastructure—no proprietary hardware required.

Ongoing Support & Training

Intuitive interface with clinical & technical support for onboarding and use.

BROCHURE

Download the Continuous Monitoring for Ketamine Clinics Overview

Learn how Vios is prioritizing patient safety by providing clinicians real-time visibility across every ketamine infusion session.

Download the Ketamine Clinic Brochure

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please enter your email below to download the brochure.
By submitting this form you agree that Vios may email you regarding relevant products and services. You can unsubscribe from these emails at any time.

Ready to bring real-time visibility to your infusion program?

References:
1.Lakhan SE, Kirley K, Todd J, et al. Intravenous ketamine for depression: a clinical discussion reconsidering best practices in acute hypertension management. Front Psychiatry. 2022;13:1017504.
2. Yaakub SN, Lazartigues E, Lapidus KA, et al. Ketamine for depressive symptoms: a retrospective chart review of an outpatient psychiatric clinic. J Clin Psychopharmacology. 2021;41(3):276–281

See Instructions for Use (IFU) for full system details and important safety information.